Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
04 Dec 2019 Weekly Dose-Dense Chemotherapy Does Not Improve PFS in First-Line Treatment for Epithelial Ovarian Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
03 Dec 2019 Fostamatinib Received a Positive Opinion from the EMA for the Treatment of Primary Immune Thrombocytopenia Haematologic malignancies
02 Dec 2019 People with Mental Illness Receive Less Cancer Screening Cancer in Special Situations / Population - Epidemiology/Etiology/Cancer Prevention
29 Nov 2019 Randomised Trial of Supplemental MRI Screening in Women with Extremely Dense Breast Tissue Breast cancer - Epidemiology/Etiology/Cancer Prevention
28 Nov 2019 EMA Recommends Granting a Conditional Marketing Authorisation for Polatuzumab Vedotin Haematologic malignancies - Anticancer agents & Biologic therapy
27 Nov 2019 First-line Treatment with Osimertinib Associated with Longer OS in EGFR Mutation–positive Advanced NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
26 Nov 2019 FDA Approves Acalabrutinib for CLL and SLL Haematologic malignancies - Anticancer agents & Biologic therapy
25 Nov 2019 EMA Recommends Extension of Indications for Lenalidomide Haematologic malignancies - Anticancer agents & Biologic therapy
23 Nov 2019 Atezolizumab in Combination with Bevacizumab Provides Superior Outcome Compared with Sorafenib in Unresectable HCC Gastrointestinal cancers - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
22 Nov 2019 Unique Factors Impact Outcome in AYA Patients with Cancer Cancer in Special Situations / Population
21 Nov 2019 Exploratory Analysis of FIRE-3 According CRC Consensus Molecular Subgroups Gastrointestinal cancers - Translational research
20 Nov 2019 Adding Isatuximab to Pomalidomide and Low-Dose Dexamethasone Improves PFS in Relapsed and Refractory Multiple Myeloma Haematologic malignancies - Anticancer agents & Biologic therapy
19 Nov 2019 FDA Grants Accelerated Approval to Zanubrutinib for Mantle Cell Lymphoma Haematologic malignancies - Anticancer agents & Biologic therapy
18 Nov 2019 EMA Recommends Extension of Indications for Trastuzumab Emtansine Breast cancer - Anticancer agents & Biologic therapy
15 Nov 2019 Secondary Surgical Cytoreduction Followed by Chemotherapy vs Chemotherapy in Recurrent Ovarian Cancer Gynaecologic malignancies